Clinical Trials on Immune-related Adverse Events in Austria

Total 423 results

Abbott Medical Devices

Completed

Lead Registry for Optim Leads (OPTIMUM)

Optim Lead Insulation Related Adverse Events

United States, Belgium, Germany
Insel Gruppe AG, University Hospital Bern
The Hospital for Sick Children; Children's Hospital of Philadelphia; Charite... and other collaborators

Recruiting

CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation (CRICKET)

Intubation Complication | Adverse Events

United States, Australia, Canada, Germany, Switzerland
Medical University of Graz

Completed

Haemodynamic Effects of Oxytocin and Carbetocin

Pregnancy Related | Cesarean Section; Complications | Adverse Reaction to Oxytocic Agents

Austria
Société des Produits Nestlé (SPN)
Waldkrankenhaus Protestant Hospital, Spandau; Kinderarztpraxis Köllges, Mossakowski... and other collaborators

Completed

Human Milk Oligosaccharides (HMOs) Post-market Study on Infants (NEHMO) (NeHMO DACH)

Growth | Tolerance | Adverse Event | Disorder of Intestine | Formula Satisfaction

Austria, Germany, Switzerland
J.J.Swen
Karolinska Institutet; Medical University of Vienna; Uppsala University; St. Antonius... and other collaborators

Completed

PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions (PREPARE)

Adverse Drug Reaction

Austria, Netherlands, Italy, Greece, Slovenia, Spain, United Kingdom
Murdoch Childrens Research Institute

Recruiting

Minimising Adverse Drug Reactions and Verifying Economic Legitimacy in Children (MARVEL-PIC) (MARVEL-PIC)

Neoplasms | Bone Marrow Transplantation

Australia
The Alfred
National Health and Medical Research Council, Australia; Monash University

Withdrawn

Predictors of Drug Hypersensitivity in HIV Infected Subjects

HIV Infections | Hypersensitivity

Australia
Flinders University
Flinders Medical Centre; Lyell McEwin Hospital

Recruiting

Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors (MIICI)

Myocardial Injury | Myocarditis | Cardiotoxicity | Immune Checkpoint Inhibitors

Australia
Andreas Benesic, MD
MetaHeps GmbH

Unknown

Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and Hepatotoxicity

Adverse Reaction to Drug | Drug-induced Disorder of Liver

Hong Kong, Australia, Germany, Japan, Korea, Republic of
Queensland Centre for Gynaecological Cancer
GlaxoSmithKline Research & Development Limited

Not yet recruiting

SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr) (SATELLITE)

Mmr Deficiency | Endometrial Cancer Stage I | Immune-related Adverse Event | Endometrioid Endometrial Adenocarcinoma

Australia
Medical University of Graz

Completed

The Influence of Tramadol on Platelet Function

Drug Toxicity | Platelet Dysfunction | Clotting Disorder

Austria
Companion Dx Reference Lab, LLC

Unknown

Utility of PharmacoGenomics for Reducing Adverse Drug Effects (UPGRADE)

Genetics of Drug Metabolism

United States
Medical University of Vienna

Unknown

Long-term Follow-up of Subfoveal Neovascular AMD

Exudative Age-related Macular Degeneration

Austria
Medical University of Graz

Completed

Vitamin D Supplementation and Regulatory FoxP3+ T Cells in the GUT

Immune Tolerance

Austria
Arbeitsgemeinschaft medikamentoese Tumortherapie

Completed

Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma (NHL-14)

Diffuse Large B-Cell Lymphoma

Austria
Medical University of Graz

Completed

Immune and Metabolic Effects of Vitamin D Supplementation in Healthy Humans

Healthy Humans

Austria
Medical University of Graz

Completed

A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial (ENM-HS-001)

Diabetes, Type I

Austria
Medical University of Graz
European Commission

Completed

Feasibility Study to Determine the Optimal Calibration Method for Glucose Sensors (REACT4SENSOR)

Diabetes

Austria
Decibel Therapeutics

Completed

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

Ototoxicity

United States, Australia
Royal Prince Alfred Hospital, Sydney, Australia

Completed

Cardiotoxicity of Adjuvant Trastuzumab (CATS)

Heart Failure | Breast Neoplasms

Australia
Medical University of Graz
Graz University of Technology

Not yet recruiting

Methimazole in Graves' Disease - Comparing the Computer-aided Treatment DigiThy Versus Usual Care

Graves Disease

Austria
Medical University of Vienna

Completed

Effect of High-Dose Prednisolone (Solu Dacortin®) Treatment on Choroidal and Optic Nerve Head Blood Flow in Humans

Regional Blood Flow | Optic Disk

Austria
Novo Nordisk A/S

Completed

A Study to Look at How Safe Insulin NNC0471-0119 is and How it Works in People With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Austria
Arecor Limited

Completed

AT278 and NovoRapid® in Glucose Clamp Study

Diabetes Mellitus, Type 1

Austria
Eli Lilly and Company

Completed

A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue

Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Medical University of Vienna
National Bank of Austria

Unknown

Interventions to Prevent Adolescents With Type 1 Diabetes From Long-term Complications

Diabetes Mellitus, Type 1

Austria
Radboud University Medical Center
Assistance Publique - Hôpitaux de Paris; Medical University of Vienna; KU Leuven and other collaborators

Recruiting

A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass (Ver-A-image)

Diabetes Mellitus

France, Austria
Novo Nordisk A/S

Completed

A Study to Look at How Insulin NNC0471-0119 Works in the Body in People With Type 1 Diabetes When Injected by Insulin Pump

Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

Comparison of Two NN1250 Formulations in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It Works

Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

Investigating the Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Arecor Limited

Completed

AT247, NovoRapid® and Fiasp® in Glucose Clamp Study

Diabetes Mellitus, Type 1

Austria
German Diabetes Center

Completed

Phielix et al.: Hepatic Fat Content and Adipokines

Type 2 Diabetes Mellitus

Austria
Medical University of Graz

Active, not recruiting

Severe Immune Cytopenia Registry Www.Sic-reg.Org (sic-reg)

Primary Immunodeficiency | Immune Thrombocytopenia | Autoimmune Hemolytic Anemia | Evans Syndrome

Austria
Novo Nordisk A/S

Completed

The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Medical University of Graz
Menarini Group

Completed

Accuracy, Reliability and Safety of GlucoMen®Day, a New Generation Microdialysis Continuous Glucose Monitor

Type 1 Diabetes

Austria
Vanderbilt University Medical Center
University of Colorado, Denver; Juvenile Diabetes Research Foundation; University... and other collaborators

Enrolling by invitation

Multicenter Assessment of the Pancreas in Type 1 Diabetes (MAP-T1D)

Diabetes Mellitus

United States, Australia
Medical University of Graz

Completed

Incretin Effect on the Immunological Phenotype

Type 1 Diabetes

Austria
Medical University of Graz
Medical University of Vienna

Completed

Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 Diabetes

Type 1 Diabetes

Austria
Medical University of Graz
Menarini Group

Completed

Performance Study to Test the GlucoMen®Day System Using Intravascular and Subcutaneous Microdialysis in Subjects With Type 1 Diabetes

Type 1 Diabetes

Austria
Landsteiner Institut
University of Coimbra

Completed

Non Invasive Assessment of Liver Glycogen Kinetics and ATP Synthesis in Type1 Diabetics

Type 1 Diabetes Mellitus

Austria

Clinical Trials on Immune-related Adverse Events in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations